Several new drugs for advanced prostate cancer were approved in the past few years, and the pipelines are bristling with compounds that have diverse mechanisms of action. This article examines current and upcoming treatment modalities and provides a market outlook for prostate cancer.
- Dominic Trewartha
- Kimberley Carter